Susquehanna International Group
IMUC.WS

Susquehanna International Group’s ImmunoCellular Therapeutics Ltd. IMUC.WS Stock Holding History

Susquehanna International Group’s Portfolio IMUC.WS Stock Details IMUC.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-43,100
Closed -$2K – 10727
2017
Q4 		$2K Sell
43,100
-50,637
-54% -$2.3K ﹤0.01% 9142
2017
Q3 		$2K Hold
93,737
– – ﹤0.01% 8717
2017
Q2 		$2K Hold
93,737
– – ﹤0.01% 9096
2017
Q1 		$25K Hold
93,737
– – ﹤0.01% 8702
2016
Q4 		$47K Buy
+93,737
New +$31.9K ﹤0.01% 9306

Other funds holding IMUC.WS

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Susquehanna International Group's IMUC.WS Position: Q1 2018 in Review

Susquehanna International Group sold out of ImmunoCellular Therapeutics Ltd. (IMUC.WS) in Q1 2018, closing a stake of 43,100 shares — an estimated $2K sold.

Susquehanna International Group first reported a position in IMUC.WS in Q4 2016 and held it in 5 quarters. The position peaked at $47K in Q4 2016. 1 fund tracked by Wall St. Rank holds IMUC.WS as of Q1 2018.

  • Susquehanna International Group reported no remaining ImmunoCellular Therapeutics Ltd. position as of Q1 2018 after selling out during the quarter.
  • Susquehanna International Group sold 43,100 ImmunoCellular Therapeutics Ltd. shares in Q1 2018, an estimated $2K.
  • Susquehanna International Group first reported a position in ImmunoCellular Therapeutics Ltd. in Q4 2016 and held it in 5 quarters.
  • Susquehanna International Group's ImmunoCellular Therapeutics Ltd. position peaked at $47K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held ImmunoCellular Therapeutics Ltd. as of Q1 2018.

Based on Susquehanna International Group's 13F filing for Q1 2018, filed 15 May 2018.